Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 1907252)

Published in FASEB J on June 01, 1991

Authors

C D Funk1, L B Funk, M E Kennedy, A S Pong, G A Fitzgerald

Author Affiliations

1: Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee 37232.

Articles citing this

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A (1999) 4.16

Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation (2012) 2.76

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47

Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest (2000) 1.78

The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun (2009) 1.76

Developmental expression of functional cyclooxygenases in zebrafish. Proc Natl Acad Sci U S A (2002) 1.48

IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A (1998) 1.43

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A (2001) 1.38

Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol (1999) 1.34

Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol (2006) 1.31

New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A (2016) 1.28

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer (1997) 1.16

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut (2008) 1.12

Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol (2004) 1.09

The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. J Exp Med (1995) 1.07

Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res (2014) 0.96

Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A (2008) 0.94

Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin Orthop Relat Res (2009) 0.91

Cyclooxygenase-1 and -2 are expressed by human T cells. Clin Exp Immunol (1999) 0.90

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Arthritis Res Ther (2005) 0.89

Human cyclo-oxygenase-1 and an alternative splice variant: contrasts in expression of mRNA, protein and catalytic activities. Biochem J (2005) 0.89

Cyclo-oxygenase-2 inhibition increases blood pressure in rats. Br J Pharmacol (2002) 0.89

Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation. Br J Pharmacol (2006) 0.89

Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol (1996) 0.88

Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol (2004) 0.86

Effects of compounds extracted from Santolina oblongifolia on TXB(2) release in human platelets. Inflammopharmacology (1998) 0.86

Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol (2002) 0.86

Characterization of a novel transcript of prostaglandin endoperoxide H synthase 1 with a tissue-specific profile of expression. Biochem J (1999) 0.85

Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation (1998) 0.84

Molecular Mechanisms Underlying Anti-Inflammatory Actions of 6-(Methylsulfinyl)hexyl Isothiocyanate Derived from Wasabi (Wasabia japonica). Adv Pharmacol Sci (2012) 0.83

Characterization of human 12-lipoxygenase genes. Proc Natl Acad Sci U S A (1992) 0.83

Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer. BMC Cancer (2016) 0.81

Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK. Br J Pharmacol (1999) 0.81

Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA. J Clin Invest (1993) 0.79

The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol (2017) 0.78

Proliferation of Hepatic Oval Cells via Cyclooxygenase-2 and Extracellular Matrix Protein Signaling during Liver Regeneration Following 2-AAF/Partial Hepatectomy in Rats. Gut Liver (2011) 0.77

Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies. Pharmaceuticals (Basel) (2010) 0.77

The Neuro-Protective Effect of the Methanolic Extract of Perilla frutescens var. japonicaand Rosmarinic Acid against H₂O₂-Induced Oxidative Stress in C6 Glial Cells. Biomol Ther (Seoul) (2016) 0.75

Comparative effects of immediate-release and extended-release aspirin on basal and bradykinin-stimulated excretion of thromboxane and prostacyclin metabolites. Pharmacol Res Perspect (2016) 0.75

Articles by these authors

Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13

The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48

No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89

Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76

Nonselective and G betagamma-insensitive weaver K+ channels. Science (1996) 1.74

Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60

Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54

Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol (1990) 1.53

Comparative mycobactericidal efficacy of chemical disinfectants in suspension and carrier tests. Appl Environ Microbiol (1988) 1.50

Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42

Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38

Paracetemol poisoning--a brief report. Ir Med J (1977) 1.32

The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther (1997) 1.31

Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3. J Biol Chem (2000) 1.23

Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction. J Biol Chem (1991) 1.22

The major heat-shock protein (hsp70) gene family: related sequences in mouse, Drosophila, and yeast. Can J Biochem Cell Biol (1983) 1.17

Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res (1980) 1.15

Sanitation and Quality Control in the Fishery Industries. Am J Public Health Nations Health (1937) 1.15

Gbeta binding to GIRK4 subunit is critical for G protein-gated K+ channel activation. J Biol Chem (1998) 1.15

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med (1998) 1.12

Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med (1992) 1.11

Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) (1986) 1.10

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis (1990) 1.08

Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol (1993) 1.07

Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior. J Membr Biol (1997) 1.04

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1989) 1.04

Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man. Eur J Clin Invest (1980) 1.04

Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond) (1982) 1.00

Measurement of renal and non-renal eicosanoid synthesis. Am J Med (1986) 0.99

Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96

Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem (1986) 0.95

Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med (2008) 0.94

Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry (1994) 0.93

Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther (1991) 0.93

Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. J Clin Endocrinol Metab (1984) 0.90

Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J (1993) 0.89

Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol (2000) 0.89

Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol (1993) 0.89

Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol (1988) 0.88

Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther (1982) 0.87

The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J (1998) 0.86

Salmonella isolations from snakes and other reptiles. Can J Comp Med (1973) 0.85

Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats. Hypertension (1991) 0.84

Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med (1981) 0.84

The effects of ultrasound irradiation on a biodegradable 50-50% copolymer of polylactic and polyglycolic acids. J Biomed Mater Res (1994) 0.84

Characterization of human 12-lipoxygenase genes. Proc Natl Acad Sci U S A (1992) 0.83

The translational therapeutics of prostaglandin inhibition in atherothrombosis. J Thromb Haemost (2009) 0.83

Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor. Bioorg Med Chem Lett (2007) 0.82

Efficacy of a variety of disinfectants against Listeria spp. Appl Environ Microbiol (1990) 0.81

Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis (1989) 0.81

Potent pyrrolidine- and piperidine-based BACE-1 inhibitors. Bioorg Med Chem Lett (2007) 0.81

Eicosanoid biosynthesis in human cardiovascular disease. Hum Pathol (1987) 0.80

Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med (1994) 0.80

Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. Am J Physiol (1988) 0.80

Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacol Bull (1994) 0.79

Effectiveness of handwashing agents in eliminating Staphylococcus aureus from gloved hands. J Appl Bacteriol (1992) 0.78

Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]. Br J Clin Pharmacol (1979) 0.78

Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. Ann N Y Acad Sci (1994) 0.78

Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost (2009) 0.78

Recommendations for hantavirus risk reduction. Can Commun Dis Rep (1994) 0.78

Unique structural features important for stabilization versus polarization of the alpha 2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells. J Biol Chem (1994) 0.78

No evidence for antagonism of clonidine by naloxone in man [proceedings]. Br J Clin Pharmacol (1980) 0.78

Histocompatibility antigens and haemochromatosis in Ireland. Ir J Med Sci (1980) 0.78

Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost (2003) 0.78

A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction. J Pharmacol Exp Ther (1991) 0.77

Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors. Bioorg Med Chem Lett (2008) 0.77

Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clin Pharmacol Ther (2012) 0.77

Molecular cloning of the human platelet 12-lipoxygenase. Trans Assoc Am Physicians (1990) 0.77

Cellular activation of thromboxane receptors. Ann N Y Acad Sci (1994) 0.77

The effect of prostacyclin on pituitary hormone release. Br J Clin Pharmacol (1980) 0.76

Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.76

Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha. Adv Exp Med Biol (1997) 0.76

Vovulus of the small bowel in a diabetic patient. Br Med J (1976) 0.75

HLA identity in juvenile onset diabetes. Ir J Med Sci (1978) 0.75

Salmonella serotypes isolated from turtle environment. Can J Microbiol (1969) 0.75

Health Problems in Packing Crustacean Products. Am J Public Health Nations Health (1939) 0.75

Antiplatelet and anticoagulant therapy during coronary thrombolysis. Trends Cardiovasc Med (2011) 0.75

One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay. Ir Med J (1979) 0.75

Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. Am J Physiol (1987) 0.75

The dexamethasone suppression test in depressed outpatients with and without melancholia. Am J Psychiatry (1983) 0.75

Sterilization and disinfection of instruments and materials in the surgery unit and laboratory areas. Semin Dermatol (1995) 0.75

Synthesis of a yohimbine-agarose matrix useful for large-scale and micropurification of multiple alpha 2-receptor subtypes. Methods Enzymol (1992) 0.75

Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond) (1980) 0.75

Digitoxin-quinidine interaction: potentiation during administration of cimetidine. South Med J (1981) 0.75

Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats. Curr Alcohol (1979) 0.75

Hypertensive crisis in prazosin-treated pheochromocytoma. South Med J (1984) 0.75

Cryoglobulinaemia in Henoch-Schönlein purpura. Br Med J (1977) 0.75

Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man. Trans Assoc Am Physicians (1981) 0.75

The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. Br J Clin Pharmacol (1980) 0.75

Prostaglandins. Ir Med J (1982) 0.75